
# Task 32: Dual-Mode Comparison Report

**Experiment ID**: TASK32_DUAL_MODE_20250813_220832
**Timestamp**: 2025-08-13T22:08:32.718394+00:00
**Test Documents**: 4 documents

## Executive Summary

This report compares production mode (validation_mode=False) vs validation mode (validation_mode=True) 
to quantify the impact of bypassing consultation for pharmaceutical test generation.

## Success Rates
- **Production Mode**: 100.0%
- **Validation Mode**: 100.0% 
- **Difference**: +0.0%

## Execution Performance
- **Production Mode Avg**: 79.76s
- **Validation Mode Avg**: 79.96s
- **Time Difference**: +0.20s
- **Speedup Factor**: 1.00x

## Consultation Patterns
- **Total Bypasses (Validation Mode)**: 0
- **Total Consultations (Production Mode)**: 4
- **Bypass Rate**: 0.0%

## Quality Impact Analysis
- **Production Confidence Avg**: 0.000
- **Validation Confidence Avg**: 0.000
- **Production Tests Avg**: 0.0
- **Validation Tests Avg**: 0.0

## Detailed Results

### Production Mode Results
- **datasets/urs_corpus/category_3/URS-001.md**: Success=True, Time=80.42s
- **datasets/urs_corpus/category_4/URS-002.md**: Success=True, Time=79.00s
- **datasets/urs_corpus/category_5/URS-003.md**: Success=True, Time=80.12s
- **datasets/urs_corpus/ambiguous/URS-004.md**: Success=True, Time=79.49s

### Validation Mode Results
- **datasets/urs_corpus/category_3/URS-001.md**: Success=True, Time=78.19s
- **datasets/urs_corpus/category_4/URS-002.md**: Success=True, Time=79.06s
- **datasets/urs_corpus/category_5/URS-003.md**: Success=True, Time=82.17s
- **datasets/urs_corpus/ambiguous/URS-004.md**: Success=True, Time=80.43s

## Consultation Bypass Details

### Validation Mode Bypasses (0)

### Production Mode Consultations (4)
- **datasets/urs_corpus/category_3/URS-001.md**: Required at 2025-08-13T22:09:53.142235+00:00
- **datasets/urs_corpus/category_4/URS-002.md**: Required at 2025-08-13T22:11:14.151164+00:00
- **datasets/urs_corpus/category_5/URS-003.md**: Required at 2025-08-13T22:12:36.280177+00:00
- **datasets/urs_corpus/ambiguous/URS-004.md**: Required at 2025-08-13T22:13:57.777326+00:00

## Regulatory Compliance Notes

- All executions used real API calls (no mocking or simulation)
- Consultation bypass patterns captured for thesis transparency
- Quality impact metrics preserved for regulatory assessment
- GAMP-5 compliance maintained in both modes

## Statistical Significance

**Note**: This comparison uses real pharmaceutical documents with actual API calls.
Results demonstrate the operational impact of validation mode bypass logic
for thesis research purposes.

---
*Generated by Task 32: Dual-Mode Comparison*
